| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | D S Goldstein | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 86-99 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Plasma catecholamines and essential hypertension. An analytical review | |
| P478 | volume | 5 |
| Q41559306 | A hypothesis linking intracellular sodium, membrane receptors, and hypertension |
| Q39746514 | A possible role of epinephrine in the development of hypertension |
| Q35822242 | Abnormal intracellular calcium homeostasis in sympathetic neurons from young prehypertensive rats |
| Q40693524 | Abnormalities of autonomic nervous control in human hypertension |
| Q36880858 | Accumulation and release of adrenaline, and the modulation by adrenaline of noradrenaline release from rabbit blood vessels in vitro |
| Q48421045 | Acute systemic and regional hemodynamic effects of alpha 1-adrenoceptor blockade in conscious spontaneously hypertensive rats |
| Q36797394 | Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes |
| Q44188991 | Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart |
| Q72643334 | Analysis of biogenic amines in plasma of hypertensive patients and a control group |
| Q40143632 | Angiotensin-converting enzyme 2: a new target for neurogenic hypertension |
| Q104910364 | Antihypertensive Activity ofdl-Tetrahydropalmatine, an Active Alkaloid Isolated from the Tubers ofCorydalis racemosa |
| Q34196370 | Antihypertensive drugs and sympathetic nervous system. |
| Q45873654 | Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats |
| Q61855396 | Association between sympathetic activity and the atherogenic serum cholesterol fraction |
| Q73426727 | Autonomic response to change of posture among normal and mild-hypertensive adults: investigation by time-dependent spectral analysis |
| Q36244806 | Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease |
| Q44985731 | Beta2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese |
| Q56444058 | Biochemical and Galvanic Skin Responses to Music Stimuli by College Students in Biology and Music |
| Q35095473 | Biological mechanisms in the relationship between depression and heart disease |
| Q54716618 | Blood pressure and sympathetic activity following responses to aerobic exercise in patients with essential hypertension. |
| Q41361517 | Blood pressure responses to ACTH and adrenaline infusions in dogs |
| Q38657623 | Brain and the regulation of blood pressure: a hemodynamic perspective |
| Q44941421 | Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system |
| Q44861750 | Cardiac phenylethanolamine N-methyltransferase: localization and regulation of gene expression in the spontaneously hypertensive rat. |
| Q37097113 | Cardiovascular and metabolic effects of obesity. |
| Q47807900 | Cardiovascular autonomic regulation in subjects with normal blood pressure, high-normal blood pressure and recent-onset hypertension |
| Q48247262 | Cardiovascular effects of partial sleep deprivation in healthy volunteers. |
| Q36862501 | Cardiovascular manifestations of posttraumatic stress disorder |
| Q70029064 | Cardiovascular regulation during administration of co-dergocrine to normal subjects |
| Q40905068 | Catecholamines and essential hypertension |
| Q34442323 | Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids |
| Q37186153 | Central sympathetic overactivity: maladies and mechanisms |
| Q53679705 | Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats. |
| Q38090531 | Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure |
| Q91121458 | Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease |
| Q37474991 | Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release |
| Q67802466 | Comparative effects of adrenaline and noradrenaline on the synthesis and secretion of soluble protein by isolated hepatocytes |
| Q46480512 | Comparison of cardiac versus vascular reactors and ethnic groups in plasma epinephrine and norepinephrine responses to stress |
| Q48582590 | Decreased pituitary response to insulin-induced hypoglycaemia in young lean male patients with essential hypertension |
| Q69517399 | Determination of free and total catecholamines and salsolinol in urine by ion-pair reversed-phase liquid chromatography with electrochemical detection after a one-step sample clean-up |
| Q37911259 | Dietary methyl-consuming compounds and metabolic syndrome |
| Q44728279 | Differential regulation of atrial contraction by P1 and P2 purinoceptors in normotensive and spontaneously hypertensive rats |
| Q35027775 | Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. |
| Q34317643 | Do most antihypertensive agents have a sympatholytic action? |
| Q46528131 | Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men. |
| Q41947176 | Does norepinephrine influence pain behavior mediated by dorsal root ganglia?: a pilot study |
| Q39818623 | Dopamine receptors: functions, subtypes and emerging concepts |
| Q33697666 | Drug treatment--antihypertensive drugs--the present role of beta blockers and alpha blockers |
| Q50046610 | Effects of fentanyl on cardiovascular response during rapid sequence induction in hypertensive patients |
| Q52011077 | Effects of increased arterial epinephrine on insulin, glucose and phosphate. |
| Q44536056 | Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment |
| Q44249710 | Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. |
| Q43606732 | Effects of psychological and physical covariates on plasma catecholamines in borderline hypertensives and offspring of hypertensive parents |
| Q35027144 | Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. |
| Q42139794 | Electrodermal responsivity in young hypotensive and hypertensive men. |
| Q35108765 | Elevated vertebrobasilar artery resistance in neonatal spontaneously hypertensive rats |
| Q44399951 | Endocrine abnormalities in patients with central serous chorioretinopathy |
| Q47107918 | Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection-A Proof-of-Concept Study. |
| Q35811926 | Epinephrine facilitates neurogenic vasoconstriction in humans |
| Q37188610 | Essential hypertension and the sympathetic nervous system |
| Q44854495 | Ethnicity, gender, and age effects on adrenoceptors and physiological responses to emotional stress |
| Q27026213 | Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks |
| Q35069805 | Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model |
| Q69727949 | Evidences of a sympatho-adrenal dysfunction after lesion of the central noradrenergic pathways in rats |
| Q97424266 | Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit |
| Q44471154 | Exercise induces excessive normetanephrine responses in hypertensive diabetic patients |
| Q42496719 | Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine |
| Q72567146 | Facilins, a novel class of biological factors that facilitate the aortic response to dopamine and other biogenic amines |
| Q35751337 | Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension |
| Q56648670 | Free and Conjugated Catecholamines in Plasma and Red Blood Cells of Normotensive and Hypertensive Patients |
| Q38405015 | Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension |
| Q37067189 | Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans |
| Q51780174 | Haemodynamic changes under emotional stress following a minor surgical procedure under local anaesthesia. |
| Q35520767 | Heart and mind: (1) relationship between cardiovascular and psychiatric conditions |
| Q69947092 | Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertension |
| Q33865993 | Heterotrimeric G proteins in heart disease |
| Q41138497 | Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo |
| Q64238394 | Increased arterial pressure in mice with overexpression of the ADHD candidate gene calcyon in forebrain |
| Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
| Q54054322 | Insulin and hypertension in the NHLBI Family Heart Study: a sibpair approach to a controversial issue. |
| Q51586009 | Insulin resistance and sympathetic nervous system activity in hypertensive and normotensive premenopausal women. |
| Q34958515 | Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases |
| Q39303934 | Inter-population comparisons of catecholamine excretion |
| Q48162668 | Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes |
| Q41126316 | Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? |
| Q37324756 | L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats |
| Q48000879 | Lack of relationship between sympathetic nervous system activity, measured by two circulating markers, and blood pressure in diabetic and nondiabetic subjects |
| Q34187537 | Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis |
| Q36107875 | Long-term recording of sympathetic nerve activity: the new frontier in understanding the development of hypertension? |
| Q42493195 | Lymphocyte basal cyclic AMP production predicts blood pressure |
| Q35578919 | Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension |
| Q85368639 | Mechanisms of delayed inotropic response of mouse atria to activation of β(2)-adrenoreceptors |
| Q85161196 | Modulation of plasma adrenomedullin by epinephrine infusion during head up tilt |
| Q36280663 | Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea |
| Q37269607 | Neural and nonneural mechanisms for sex differences in elderly hypertension: can exercise training help? |
| Q38191400 | Neuroadrenergic disarray in pseudo-resistant and resistant hypertension |
| Q52047668 | Neuroendocrine and Cardiovascular Stress Reactivity in Middle-Aged Normotensive Adults with Parental History of Cardiovascular Disease |
| Q36824063 | Neuroimmune communication in hypertension and obesity: a new therapeutic angle? |
| Q35116071 | Neuronal and non-neuronal modulation of sympathetic neurovascular transmission |
| Q33939221 | No elevated plasma catecholamine levels during sleep in newly diagnosed, untreated hypertensives |
| Q34028169 | Obesity, hypertension, and sympathetic nervous system activity |
| Q34028263 | Obstructive sleep apnea as a cause of neurogenic hypertension. |
| Q46927669 | Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats |
| Q37892042 | Paracrine control of vascular innervation in health and disease |
| Q37094953 | Pathogenesis of essential hypertension: historical paradigms and modern insights |
| Q38657653 | Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension |
| Q70139808 | Pathophysiology of hypertension in the elderly |
| Q39561130 | Pathophysiology of sympathoadrenal system |
| Q52067412 | Pharmacologic and tracer methods to study sympathetic function in primary hypertension. |
| Q34206883 | Pioneer Award Address: ignorance isn't biased: comments on receiving the Pioneer Award |
| Q36256102 | Plasma Metanephrines Are Associated With Glucose Metabolism in Patients With Essential Hypertension |
| Q68449404 | Plasma catecholamines and heart rate at the beginning of muscular exercise in man |
| Q40905051 | Plasma catecholamines--analytical challenges and physiological limitations |
| Q41742885 | Plasma epinephrine levels in hypertension and across gender and ethnicity |
| Q36053212 | Platelet alpha2-adrenoceptor alterations in patients with essential hypertension |
| Q44585732 | Poly(norepinephrine): ultrasmooth material-independent surface chemistry and nanodepot for nitric oxide |
| Q69031139 | Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension |
| Q37151236 | Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing |
| Q39470203 | Pre- and postjunctional beta-adrenoreceptors and hypertension |
| Q37895598 | Presynaptic receptors in hypertension |
| Q37589007 | Primary hypertension and special aspects of hypertension in older children and adolescents |
| Q36859856 | Psychophysiological theories on sympathetic nervous system reactivity in the development of essential hypertension |
| Q69694862 | Psychosocial stress and reactivity as risk factors of cardiovascular disease |
| Q52077313 | Pulmonary vascular supersensitivity to catecholamines in systemic high blood pressure. |
| Q45802257 | Regional norepinephrine turnover in human hypertension |
| Q71388077 | Regulation of neuromodulatory actions of angiotensin II in the brain neurons by the Ras-dependent mitogen-activated protein kinase pathway |
| Q43565194 | Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms. |
| Q42013990 | Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs |
| Q38176764 | Renal denervation: transition from pathophysiology to clinical practice |
| Q34416874 | Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide |
| Q34642358 | Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene |
| Q46514659 | SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats |
| Q39300986 | School burnout and cardiovascular functioning in young adult males: a hemodynamic perspective |
| Q39123155 | School burnout: increased sympathetic vasomotor tone and attenuated ambulatory diurnal blood pressure variability in young adult women |
| Q44951181 | Selective alpha(1)-adrenoceptor blockade prevents fructose-induced hypertension |
| Q36552496 | Selective α1-adrenoreceptor blockers in the treatment of hypertension: Should we be using them more? |
| Q47396920 | Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats |
| Q33604183 | Sleep apnoea and systemic hypertension |
| Q46218580 | Sources of human urinary epinephrine |
| Q38950247 | Stress mechanisms in hypertension |
| Q40387883 | Stress response and antihypertensive treatment |
| Q37035595 | Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models |
| Q42471518 | Sympathetic and respiratory responses to hypoxia in essential hypertension |
| Q35170115 | Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options |
| Q34037802 | Sympathetic vasomotor tone is associated with depressive symptoms in young females: a potential link between depression and cardiovascular disease |
| Q35191565 | Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass |
| Q37614066 | Sympathoneural and adrenomedullary responses to mental stress |
| Q41129129 | Systemic Hypertension in Snorers with and without Sleep Apnea |
| Q54420223 | Systemic systolic hypertension in the elderly: correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy. |
| Q28510519 | Targeted disruption of the beta2 adrenergic receptor gene |
| Q37653115 | The 'neuroadrenergic hypothesis' in hypertension: current evidence. |
| Q36813463 | The Phantom in our opera - or the hidden ways of the autonomic nervous system in cardiac patients |
| Q41641392 | The activation of the kynurenine pathway in a rat model with renovascular hypertension. |
| Q39463801 | The adrenergic inhibitors. |
| Q51383384 | The chronic infusion of hexamethonium and phenylephrine to effectively clamp sympathetic vasomotor tone. A novel approach. |
| Q43157862 | The clinical evaluation of hypertension. |
| Q77525045 | The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats |
| Q70612440 | The effect of yohimbine on sympathetic responsiveness in essential hypertension |
| Q46598176 | The effects of race on norepinephrine clearance |
| Q40387921 | The pathogenesis of hypertension in obese subjects |
| Q51149520 | The relationship between blood pressure variability and catecholamine metabolites: a pilot study. |
| Q34981000 | The role of cardiac autonomic function in hypertension and cardiovascular disease |
| Q87974181 | The role of renal denervation in the treatment of hypertension |
| Q34028250 | The sympathetic nervous system and baroreflexes in hypertension and hypotension |
| Q37898511 | The sympathetic nervous system and blood pressure in humans: implications for hypertension |
| Q39749401 | The sympathetic nervous system in clinical and experimental hypertension |
| Q36116539 | Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system |
| Q33175955 | Triggering mechanism for neurally mediated syncope induced by head-up tilt test: role of catecholamines and response to propranolol |
| Q42938847 | Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study |
| Q44620731 | Unchanged G-protein-coupled receptor kinase activity in the aging human heart |
| Q42176416 | Upregulation of the Renin-Angiotensin-aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types of hypertension |
| Q53611792 | [Interventional strategies in hypertension management]. |
| Q69624366 | [Physiologic variability of plasma catecholamines] |
| Q85206861 | [Renal denervation: current state and future perspectives] |
| Q44041754 | beta-Endorphin modulation of pressor response to hyperventilation in hypertensive patients |
Search more.